Objective Although interstitial lung disease (ILD) is a major cause of morbidity and mortality
in systemic sclerosis (SSc), its prognostication remains challenging. Given that CT …

Objective The course of systemic sclerosis-associated interstitial lung disease (SSc-ILD) is
highly variable and different from continuously progressive idiopathic pulmonary fibrosis …

Introduction Interstitial lung disease (ILD) is currently the primary cause of death in systemic
sclerosis (SSc). Thoracic high-resolution computed tomography (HRCT) is considered the …

BACKGROUND Interstitial lung disease (ILD) is the leading cause of morbidity and mortality
in patients with systemic sclerosis (SSc); however, prognostication of SSc-associated ILD …

Background and objective Interstitial lung disease (ILD) is a common pulmonary
manifestation of systemic sclerosis (SSc). It is unknown whether radiographic fibrosis score …

Objectives To establish a framework by which experts define disease subsets in systemic
sclerosis associated interstitial lung disease (SSc-ILD). Methods A conceptual framework for …

Systemic sclerosis (SSc) is a systemic autoimmune disease affecting multiple organ
systems, including the lungs. Interstitial lung disease (ILD) is the leading cause of death in …

This systematic review summarises current evidence to help guide treatment decisions for
patients with systemic sclerosis (SSc)-associated interstitial lung disease (ILD). A systematic …

Rationale: Interstitial lung disease (ILD) represents a major challenge in systemic sclerosis
(SSc), but there are no precise, population-based data on its overall impact, limiting …

Interstitial lung disease (ILD) affects approximately 50% of patients with systemic sclerosis
(SSc) and is the leading cause of death in SSc. Our objective was to gain insight into the …